NCT01067573View on ClinicalTrials.gov

The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2009

Study Completion Date

July 31, 2011

Conditions
Multiple Sclerosis
Trial Locations (1)

33612

USF Health, Tampa

Sponsors

Collaborators (1)

EMD Serono
All Listed Sponsors
collaborator

EMD Serono

INDUSTRY

lead

University of South Florida

OTHER

NCT01067573 - The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment | Biotech Hunter | Biotech Hunter